China Digest: Cure Genetics nets $60m; Atom Bioscience raises over $47m

Chinese biotech startup Cure Genetics has secured $60 million in a Series B round. Separately, the country’s pharmaceutical firm Atom Bioscience has raised over 300 million yuan ($47.2 million) to fund the clinical development of its drug candidates.